Meister et al. developed mRNA-based CAR-T cells co-expressing the NKG2D receptor and pro-inflammatory cytokines IL-12 and IFNα2, which efficiently killed mouse glioma cell lines in vitro and exhibited anti-tumor activity in a glioma mouse model with intravenous and intratumoral administration [143]. Here, IFNA2 is linked to glioma.